ACROBRONQUIOL

Active ingredients

The drug ACROBRONQUIOL contains one active pharmaceutical ingredient (API):

UNII YC2ZOM3Z8V - BROMHEXINE HYDROCHLORIDE

Bromhexine is an expectorant used in the treatment of respiratory disorders associated with viscid or excessive mucus. Bromhexine is a synthetic derivative of the herbal active ingredient vasicine. It has been shown to increase the proportion of serous bronchial secretion, making it more easily expectorated. It is indicated as “secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport”.

Read about Bromhexine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Bromhexine
R Respiratory system → R05 Cough and cold preparations → R05C Expectorants, excl. combinations with cough suppressants → R05CB Mucolytics
Discover more medicines within R05CB02

Authorization and marketing

This brand name is authorized in the following countries: Ecuador

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
EC
Agencia Nacional de RegulaciĆ³n, Control y Vigilancia Sanitaria
Identifier(s): 03985-MAN-11-05, 03993-MAN-11-05, 3.965-4-01-04